Teva Pharmaceutical Industries: “Medicine Miles” Becoming a Concern for European Patients
The pandemic has sparked greater interest among patients in Europe’s role in drug manufacturing. New…
Browsing: Pharmaceutical
India News | India and Colombia explore co-production in vaccine and pharmaceutical development
New Delhi, October 3 (PTI) Colombian Foreign Minister Marta Lucia Ramirez met with senior officials…
Part 1. Conventional SPC Rules and Pharmaceutical Process Data
The first part of this series of articles demonstrates, using real-world process data, that the…
Pharmaceutical Intermediates Market Sees Huge Growth for New Standard | Menadiona, Dextra Laboratories Limited, Summit Pharmaceuticals Europe
A2Z Market Research announces the release of Pharmaceutical intermediates market research report. The market is…
Pharmaceutical Company Says Experimental Pill May Reduce Effects of COVID-19
Weather in New York: CBS2 evening forecast 10/1 at 6:00 p.m.CBS2’s Lonnie Quinn has your…
Pharmaceutical Companies Pay Over $ 400 Million To Resolve Alleged Liability Under Generic Drug Pricing False Representation Act | Takeover bid
Three generic drug makers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, have agreed…
Euro Roundup: Commission seeks comments on reform of pharmaceutical law
The European Commission is seeking comments on planned reforms aimed at addressing issues such as…
CytoReason and Summit Pharmaceuticals International Announce Introducing AI Platform at One of Japan’s Top Pharmaceutical Companies
TOKYO and TEL AVIV, Israel, September 30, 2021 / PRNewswire / – CytoReason, an AI…
Review of general EU pharmaceutical legislation – public consultation now open | Hogan Lovells
The European Commission this afternoon opened the public consultation on general EU pharmaceutical legislation on…
NRx Pharmaceuticals Announces Second Favorable Safety Report for ZYESAMI ™ (aviptadil) in NIH-Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19
– After reviewing 232 patients enrolled in the ACTIV-3b intensive care study, no new safety…